FectoPRO is a transfection reagent specifically optimized for transient protein and antibody expression in CHO and HEK293 cells.

Meet our Team and registered for our Lunch and Learn Roundtable on Wednesday April 28, 2021 from 1:10 pm - 1:50 pm (EST) !
The current challenges in Gene therapy are increasing viral titer yields, and optimizing the industrial production process of AAVs that are becoming the leading viral vector used to develop Gene therapy. Optimizing key parameters of the upstream process, such as the critical transfection step, can really accelerate the time to market of gene therapies, and in sufficient amount to address diseases with larger patient population or that require bigger doses per patient. Come to discuss with the worldwide leader in transfection Polyplus-transfection during this exciting roundtable.
Roundtable hosted by Julien DEPOLLIER, Director Strategic Partnerships at Polyplus-transfection®.